Immatics N.V. (IMTX) vs MannKind Corporation (MNKD)
- Immatics N.V. IMTX 6.72 −5.88%
- MannKind Corporation MNKD 3.04 −4.70%
Immatics N.V. and MannKind Corporation are both Biotechnology companies. Immatics N.V. and MannKind Corporation are of similar size ($1.1B and $1.0B). MannKind Corporation grew revenue faster over the last twelve months: 30.5% against −65.0%. MannKind Corporation has the higher net margin (−11.1% vs −489.4%) and the higher return on invested capital (2.36% vs −84.8%). Across the 17 metrics below, MannKind Corporation leads on 14 and Immatics N.V. on 3.
Valuation
Profitability
| Metric | IMTX | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.39% | 65.16% |
| Operating margin | (536.26%) | 2.34% | 0.00% |
| Net margin | (489.35%) | (11.08%) | 0.00% |
| Free cash flow margin | (488.01%) | (4.61%) | 0.00% |
| Return on equity | (48.53%) | 71.36% | (56.36%) |
| Return on assets | (39.83%) | (7.62%) | (48.04%) |
| Return on invested capital | (84.83%) | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack